Lee & Man Chemical Co Ltd (0746)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 20 Oct 2026
Key indicators
| Last close | HKD 4.420 |
|---|---|
| 52-week range | 3.939 – 5.975 |
| Return, 1 month / 3 months | −0.9% / −5.1% |
| Return, 1 year / 3 years | −7.2% / +67.9% |
| Trend | Below its 200-day average |
| RSI (14) | 50 |
| Volatility (1 year) | 37.3% |
| Worst drawdown (1 year) | -31.0% |
| Average daily value traded | 1.32M HKD |
| Dividend yield | 7.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Lee & Man Chemical is a Hong Kong based chemicals manufacturer that makes chlor-alkali products and related industrial chemicals. Its range includes caustic soda, chlorine, hydrogen peroxide and other chemical intermediates used by manufacturers in sectors such as paper, textiles, water treatment and general industry. The company operates production facilities and supplies customers across regional and international markets, serving industrial buyers who need bulk chemical inputs for their own manufacturing processes.
On this site Lee & Man Chemical Co Ltd appears as a stock on the Hong Kong Stock Exchange (Hong Kong), code 0746, with prices in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Lee & Man Chemical Co Ltd (0746) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 4.420 on 20 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 573 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 7.2% and over the last three months it fell 5.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 62 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -6.1% | ||
| From 52-week high | -24.3% | ||
| Momentum | 60 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -5.1% | ||
| 6-month return | -2.1% | ||
| 12-month return, skipping the last month | -6.4% | ||
| Stability (higher is calmer) | 77 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 37.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.0% | ||
| Liquidity | 63 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.32M HKD | ||
| Zero-volume days | 3.3% | ||
| Income | 70 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 7.9% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −0.7% |
|---|---|
| 1 month | −0.9% |
| 3 months | −5.1% |
| 6 months | −2.1% |
| 1 year | −7.2% |
| 3 years | +67.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 4.448 / 4.708 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.098 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Aug 2026 | HKD 0.2100 |
| 4 May 2026 | HKD 0.1400 |
| 19 Aug 2025 | HKD 0.1950 |
| 12 May 2025 | HKD 0.1500 |
| 14 Aug 2024 | HKD 0.1400 |
| 13 May 2024 | HKD 0.1400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.